Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity

Published:2021-06-21 Issue:10 Volume:21 Page:1145-1159
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Shayne Michelle¹,Harvey R. Donald²,Lyman Gary H.³^ORCID

Affiliation:

1. University of Rochester Medical Center, Rochester, NY, USA

2. Winship Cancer Institute and Emory University School of Medicine, Department of Hematology and Medical Oncology, Atlanta, GA, USA

3. Fred Hutchinson Cancer Research Center, The University of Washington, Seattle, WA, USA

Funder

BeyondSpring Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1941891

Reference132 articles.

1. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

2. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data

3. The calculation of actual or received dose intensity: a comparison of published methods.

4. Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

5. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy;Clinical Journal of Oncology Nursing;2023-09-25

2. Patient-Related Characteristics Associated with Treatment Modifications and Suboptimal Relative Dose Intensity of Neoadjuvant Chemotherapy in Patients with Breast Cancer—A Retrospective Study;Cancers;2023-04-26

3. Cell cycle arrest: A breakthrough in the supportive care of older cancer patients;Journal of the American Geriatrics Society;2023-04-10

4. Mitigating acute chemotherapy-associated adverse events in patients with cancer;Nature Reviews Clinical Oncology;2022-10-11

5. Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma;Expert Review of Anticancer Therapy;2022-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3